April FOCUS Newsletter Spotlights Colorado's Surefire Medical + More

In this issue:

Letter from CBSA President Holli Baumunk
Company Spotlight: Surefire Medical
Letter from Board Chair Steve Orndorff
Welcome New CBSA Board Members
Board of Directors Roster
The Colorado Story on Personalized Medicine
Dr. Larry Gold Q & A

Link to the pdf

Denver Post: People on the move...CBSA Leadership Announced

Quoting from the posting this morning:

"COLORADO BIOSCIENCE ASSOCIATION named Steve Orndorff, chief executive of Ariel Pharmaceuticals, as chairman. Other new officers include Derek Cole, ARCA Biopharma, vice chairman; Norwood Robb, Denver School of Science and Technology, treasurer; and Linda Pryor, Pfizer Inc., secretary. Newly appointed board members include Jeff Castleberry, EndoShape Inc.; Joe Guiles, MicroRx, CSU Ventures; Scott Hutton Sr., Medtronic Navigation; and David Mitchell, Merck & Co."

Link to denverpost.com

NCBR: 'Guiles, Lytle-Barnaby named to Colorado BioScience board'

Quoting from the article in the Northern Colorado Business Report:

"Two Northern Colorado people were named to the Colorado BioScience Association board of directors at the board's 2011 annual meeting.

Joe Guiles, executive director of MicroRx, CSU Ventures, was one of four newly appointed board members. Also appointed were Jeff Castleberry, COO, EndoShape Inc. of Boulder; Scott Hutton, senior director of global marketing, Medtronic Navigation of Louisville; and David Mitchell, executive director and plant manager, Merck and Co. Inc., Boulder.

Among six reappointments to the board was Ruth Lytle-Barnaby, executive director, Poudre Valley Health System Community and Foundation Development."

Link to the NCBR posting

Congratulations, BDEGP Early Stage Company Grant Awards Recipients - 2nd Grant Cycle

BioAMPS International Inc., Mosiac Biosciences Inc., 2CTech Corp and SuviCa Inc. have received funding from Colorado's Bioscience Discovery Evaluation Grant Program.

Of note, Proof of Concept applications are due for the 2nd competitive round by April 30th, and are still open for institutions with funds remaining in their allocation. Fiscal year 2011-12 applications and guidelines for both the Early Stage Company Proof of Concept programs will be released this summer.

Link to the Colorado OEDIT website for more information

Video Highlights of the 2011 CBSA Annual All-Member Meeting Are Now Posted

View video highlights of the 2011 CBSA Annual All-Member Meeting at the CBSA's You Tube Channel.

2010 Highlights by Rick Jory, CBSA Outgoing Board Chair


http://www.youtube.com/watch?v=A7mU2n5FpVA

Other videos:

2010 Highlights (continued) by Holli Baumunk, CBSA President & CEO
http://www.youtube.com/watch?v=6Br85XG5Mmc

2011 Looking Ahead by Holli Baumunk, CBSA President & CEO
http://www.youtube.com/watch?v=-ZBIIqr_U2M

Introduction of CBSA's New Board Members & Officers by Rick Jory, CBSA Outgoing Board Chair
http://www.youtube.com/watch?v=Ygh1WvSYaO0

Presentation by Alice Kotrlik, Deputy Director, Colorado Office of Economic Development & International Trade
http://www.youtube.com/watch?v=KgHT7Wssh4M

Presentation by Stephanie Garnica, Director Trade and Investment for the Americas, Colorado Office of Economic Development and International Trade
http://www.youtube.com/watch?v=V5qQfDe1log

BCBR: "Orndorff to lead bioscience association"

Quoting from the article by Beth Potter:

"DENVER - Ariel Pharmaceuticals founder Steve Orndorff has been tapped to head the board of directors of the Colorado BioScience Association, an industry trade group with several Boulder Valley members.

Orndorff takes over the chairman duties from Rick Jory, chief executive officer of Sandhill Scientific in Highlands Ranch. Derek Cole is the newly named vice chairman of the board. Cole is vice president at Broomfield-based ARCA biopharma Inc., a company that makes therapies for heart failure."

Link to the Boulder County Business Report

Colorado BioScience Association Names Steve Orndorff Board Chair and Appoints Four New Board Members at 2011 Annual All-Member Meeting

Steve Orndorff, Ph.D., CEO of Ariel Pharmaceuticals - http://arielpharma.com - was named chairperson of the board of directors for the Colorado BioScience Association (CBSA) at its 2011 Annual All-Member meeting held at the Colorado National Golf Club facilities in Erie, CO, yesterday. The announcement is made by Holli Baumunk, CBSA President & CEO, who says Orndorff assumes chairperson responsibilities from Rick Jory, CEO of Sandhill Scientific - http://www.sandhillsci.com -Highlands Ranch.

Newly appointed CBSA board members include: * Jeff Castleberry, COO, EndoShape, Inc. - http://endoshape.com * Joe Guiles, Ph.D., Executive Director, MicroRx, CSU Ventures – http://www.microrx.org * Scott Hutton, Sr. Director of Global Marketing, Medtronic Navigation – http://www.medtronic.com/for-healthcare-professionals/business-unit-landing-Page/Navigation * David Mitchell, Executive Director, Plant Manager, Merck & Co., Inc. – http://www.merck.com

Link to the Business Wire Release